Data as of Mar 12
| +0.0002 / +2.78%|
Information Technology Services
Intellicell Biosciences, Inc. operates as a regenerative medicine company focused on the expanding regenerative medical markets using a proprietary, patent pending process to separate adult autologous vascular cells from blood vessels in adult adipose tissue. The company has developed its own patent pending protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. It will also be seeking to develop technology licensing agreements with technology developers, universities, and international business entities. Intellicell Biosciences was founded on June 3, 2011 and is headquartered in New York, NY.
|Steven A. Victor||President, CEO, Secretary & Treasurer|
|Leonard L. Mazur||Chief Operating Officer & Director|
|Anna Rhodes||Executive Vice President-Operations|